Results: Liraglutide and semaglutide modulated both alpha and beta diversity of the gut microbiota in PCOS
But for women with a BMI over 30, weight-related comorbidities (hypertension, type 2 diabetes, sleep apnea), or psychological impacts of significant weight gain, the clinical need may be substantial
Despite their similar benefits for weight loss and muscle building, SARMs actually have nothing to do with peptides, including in structure and mechanism
In those combinations, the risk of hypoglycemia increases with any incretin therapy
Rather than trial-and-error dosing, genetic data allows your provider to recommend the right compound and starting dose from the beginning, saving time and reducing the risk of inadequate response
To support the leaders navigating these continual market changes, Virta recently hosted a live Ask Me Anything (AMA) webinar featuring our clinical, member experience, and business experts